Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002020346 | SCV002289377 | likely benign | Noonan syndrome 9 | 2023-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003170569 | SCV003911937 | uncertain significance | Cardiovascular phenotype | 2022-12-01 | criteria provided, single submitter | clinical testing | The p.F910L variant (also known as c.2730T>A), located in coding exon 17 of the SOS2 gene, results from a T to A substitution at nucleotide position 2730. The phenylalanine at codon 910 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |